KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to -$6.3 million.

  • Neogenomics' Cash from Investing Activities fell 1532.83% to -$6.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$12.3 million, marking a year-over-year decrease of 19596.27%. This contributed to the annual value of -$12.3 million for FY2025, which is 19596.27% down from last year.
  • As of Q4 2025, Neogenomics' Cash from Investing Activities stood at -$6.3 million, which was down 1532.83% from -$277000.0 recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Cash from Investing Activities registered a high of $23.7 million during Q1 2023, and its lowest value of -$453.4 million during Q2 2021.
  • For the 5-year period, Neogenomics' Cash from Investing Activities averaged around -$27.7 million, with its median value being -$2.3 million (2022).
  • As far as peak fluctuations go, Neogenomics' Cash from Investing Activities crashed by 239633.87% in 2021, and later skyrocketed by 171759.17% in 2023.
  • Over the past 5 years, Neogenomics' Cash from Investing Activities (Quarter) stood at -$9.6 million in 2021, then skyrocketed by 88.91% to -$1.1 million in 2022, then skyrocketed by 1717.59% to $17.2 million in 2023, then plummeted by 131.79% to -$5.5 million in 2024, then dropped by 15.33% to -$6.3 million in 2025.
  • Its last three reported values are -$6.3 million in Q4 2025, -$277000.0 for Q3 2025, and -$9.3 million during Q2 2025.